To the Editor:

After the rapid spread of the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) around the world, World Health Organization declared a pandemic on March 11, 2020. The SARS‐CoV‐2 pandemic is devastating due to the high mortality coronavirus disease 2019 (COVID‐19), besides putting extensive pressure on health care systems.[^1^](#pbc28595-bib-0001){ref-type="ref"} Turkey has many restrictions to control the outbreak during the pandemic period, and normalization started in June 2020.

In our study, we aimed to investigate the health problems of patients with benign hematological disorders during the restrictions period. We included children with benign hematological diseases followed in the Ministry of Health Ankara City Hospital Department of Pediatric Hematology, except those with transfusion‐dependent thalassemia major. We called the parents of the patients and filled a questionnaire about the clinical condition, inability to access medication, or health care of patients between March 10 and May 31, 2020.

We analyzed the data of 140 patients with benign hematological disorders. The median age was 12 (range 0.5‐28) years, and female/male ratio was 44/96. The majority of patients had hemophilia, acute or chronic immune thrombocytopenic purpura, or hemolytic anemia (Table [1](#pbc28595-tbl-0001){ref-type="table"}). Sixty‐five of the patients (46.4%) were taking at least one drug for their disease, and three were being treated with immunosuppressive therapy. One hundred and one patients lived in the city where our hospital is located, while others were in other cities. Five of the patients underwent a polymerase chain reaction test for COVID‐19. One patient with the diagnosis of aplastic anemia was positive for SARS‐CoV‐2 and was hospitalized. Six patients had COVID‐19‐positive relatives. During the study period, 61 patients had an appointment in our pediatric hematology clinic; however, only 18 (29.5%) patients visited the clinic. Six parents called the clinic for their children\'s health problems. Although 29 (20.7%) patients had an emergent hematological problem during this period, 18 (62%) of them were not seen by any health care provider. The most common problem was bleeding (Table [1](#pbc28595-tbl-0001){ref-type="table"}). None of our patients had any difficulty in obtaining their drugs except one with inhibitor‐positive hemophilia who lived in another city.

###### 

General characteristics and clinical problems of patients

                                                                   Number of patients (%)
  ---------------------------------------------------------------- ------------------------
  Diagnosis                                                        
  Hemophilia A                                                     44 (31.5)
  Hemophilia B                                                     6 (4.3)
  Chronic ITP                                                      38 (27.1)
  Acute ITP                                                        20 (14.3)
  Hemolytic anemia[^a^](#pbc28595-tbl1-note-0002){ref-type="fn"}   13 (9.3)
  Aplastic anemia (acquired and congenital)                        9 (6.4)
  Thrombocytopenia (other)                                         5 (3.6)
  Afibrinogenemia                                                  2 (1.4)
  Chronic neutropenia                                              1 (0.7)
  Hypersplenism                                                    1 (0.7)
  Thrombotic thrombocytopenic purpura                              1 (0.7)
  Chronic drug use                                                 
  Yes                                                              65 (46.4)
  No                                                               75 (53.6)
  Admission for routine control                                    
  Yes                                                              18 (29.5)
  No                                                               43 (70.5)
  Emergent hematological problems                                  29 (20.7)
  Joint bleeding                                                   9 (31)
  Petechiae/ecchymosis                                             9 (31)
  Epistaxis                                                        4 (14)
  Pallor                                                           3 (10.3)
  Soft tissue bleeding                                             3 (10.3)
  Hematochezia                                                     1 (3.4)
  Admission to hospital for an emergent problem                    
  Yes                                                              11 (38)
  No                                                               18 (62)

Abbreviation: ITP, immune thrombocytopenic purpura.

Autoimmune and nonimmune.
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Recent studies revealed that there is no increased mortality risk secondary to COVID‐19 in pediatric patients with immune suppression.[^2^](#pbc28595-bib-0002){ref-type="ref"}, [^3^](#pbc28595-bib-0003){ref-type="ref"} Patients with benign hematological disorders are susceptible to problems in health care. Besides infection risk, patients with chronic diseases are at risk due to the lack of admission to specialized centers during the pandemic period.[^4^](#pbc28595-bib-0004){ref-type="ref"} In Turkey during the pandemic, patients with chronic diseases were able to take their medication without a prescription if they had any reports of chronic use of the drug. This circumstance might have decreased the clinical admissions and complications. Our study revealed that the majority of patients did not attend to their routine control, and even in emergent conditions, 62% of patients did not go to any hospital. In conclusion, although none of the patients in our study had severe problems, convenient means to reach health care professions should be provided to prevent complications in children with benign hematological diseases.
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